Phase 3 randomized study of TLK286 (Telcyta) [canfosfamide] versus Gefitinib (Iressa)as third-line therapy in locally advanced or metastatic non-small cell lung cancer
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Canfosfamide; Gefitinib
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms ASSIST-2
- 03 Jun 2007 Top-line results have been reported.
- 08 Jan 2007 Interim results have been reported.
- 23 Sep 2005 New trial record.